acrimal Stability Evaluation (Three-Dimensional Image Analysis of Anterior Segment) with Rebamipide Ophthalmic Solutio
Phase 4
- Conditions
- Dry eye
- Registration Number
- JPRN-UMIN000017305
- Lead Sponsor
- Department of Ophthalmology, Ehime University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1)Epiphora with suspicion (caused by Allergic conjumctivitis) 2)Meibomian grand dysfunction 3)Atresia puncti lacrimalis (e.g., punctal plug, surgical punctal occlusion) 4)Complication with the upheaval of the keratoconjunctive (e.g., conjunctivochalasis, pterygium) 5)Anatomical and functionl palpebral abnormality (e.g., lid closure imperfection) 6)Instillation of the glaucoma therapeutic drug 7)Patients who cannot be obtained informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate tear stability treated with rebamipide ophthalmic solution
- Secondary Outcome Measures
Name Time Method